{"entity":{"type":"insider","cik":"0001275012","url":"/insider/0001275012","json_url":"/insider/0001275012.json","name":"GARRITY THOMAS J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":12,"first":"2011-03-21","last":"2021-03-12","span_basis":"filed_date"},"name_variants":[{"name":"GARRITY THOMAS J","source":"filing","n_filings":12,"first_seen":"2011-03-21","last_seen":"2021-03-12"}],"transactions":[{"id":4984719,"accession":"0001209191-21-020289","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-020289","line_url":"/filing/0001209191-21-020289#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001275012","owner_name":"GARRITY THOMAS J","owner_display_name":"GARRITY THOMAS J","owner_url":"/insider/0001275012","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":4.28,"price_display":"4.28","price_state":"stated","total_value":214000.0,"total_display":"214,000.00","total_whole":"214,000","shares_owned_after":224406.0,"shares_owned_after_display":"224,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-11","filed_date":"2021-03-12","scope":"insider"},{"id":4087590,"accession":"0001209191-21-010411","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-010411","line_url":"/filing/0001209191-21-010411#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001275012","owner_name":"GARRITY THOMAS J","owner_display_name":"GARRITY THOMAS J","owner_url":"/insider/0001275012","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":4.62,"price_display":"4.62","price_state":"stated","total_value":231000.0,"total_display":"231,000.00","total_whole":"231,000","shares_owned_after":224406.0,"shares_owned_after_display":"224,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-12","scope":"insider"},{"id":4657160,"accession":"0001209191-21-003497","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-003497","line_url":"/filing/0001209191-21-003497","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001275012","owner_name":"GARRITY THOMAS J","owner_display_name":"GARRITY THOMAS J","owner_url":"/insider/0001275012","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":4.055714285714286,"price_display":"4.06","price_state":"stated","total_value":283900.0,"total_display":"283,900.00","total_whole":"283,900","shares_owned_after":224406.0,"shares_owned_after_display":"224,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-13","scope":"insider","n_lines":2},{"id":8352293,"accession":"0001209191-19-060113","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-060113","line_url":"/filing/0001209191-19-060113","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001275012","owner_name":"GARRITY THOMAS J","owner_display_name":"GARRITY THOMAS J","owner_url":"/insider/0001275012","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":4.5809,"price_display":"4.58","price_state":"stated","total_value":366472.0,"total_display":"366,472.00","total_whole":"366,472","shares_owned_after":194186.0,"shares_owned_after_display":"194,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider","n_lines":2},{"id":7871125,"accession":"0001209191-19-027494","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-027494","line_url":"/filing/0001209191-19-027494#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001275012","owner_name":"GARRITY THOMAS J","owner_display_name":"GARRITY THOMAS J","owner_url":"/insider/0001275012","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":2.6656,"price_display":"2.67","price_state":"stated","total_value":79968.0,"total_display":"79,968.00","total_whole":"79,968","shares_owned_after":160213.0,"shares_owned_after_display":"160,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-01","filed_date":"2019-05-03","scope":"insider"},{"id":4566180,"accession":"0001209191-17-056187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-056187","line_url":"/filing/0001209191-17-056187#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001275012","owner_name":"GARRITY THOMAS J","owner_display_name":"GARRITY THOMAS J","owner_url":"/insider/0001275012","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":105000.0,"total_display":"105,000.00","total_whole":"105,000","shares_owned_after":160213.0,"shares_owned_after_display":"160,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-03","filed_date":"2017-10-05","scope":"insider"},{"id":4108545,"accession":"0001209191-17-025170","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-025170","line_url":"/filing/0001209191-17-025170#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001275012","owner_name":"GARRITY THOMAS J","owner_display_name":"GARRITY THOMAS J","owner_url":"/insider/0001275012","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":2.9092,"price_display":"2.91","price_state":"stated","total_value":87276.0,"total_display":"87,276.00","total_whole":"87,276","shares_owned_after":160213.0,"shares_owned_after_display":"160,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-31","filed_date":"2017-04-04","scope":"insider"},{"id":3254618,"accession":"0001209191-16-109783","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-109783","line_url":"/filing/0001209191-16-109783#line-1","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001275012","owner_name":"GARRITY THOMAS J","owner_display_name":"GARRITY THOMAS J","owner_url":"/insider/0001275012","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":0.72,"price_display":"0.72","price_state":"stated","total_value":21600.0,"total_display":"21,600.00","total_whole":"21,600","shares_owned_after":160213.0,"shares_owned_after_display":"160,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-18","filed_date":"2016-03-21","scope":"insider"},{"id":6184801,"accession":"0001181431-14-029132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-029132","line_url":"/filing/0001181431-14-029132#line-1","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001275012","owner_name":"GARRITY THOMAS J","owner_display_name":"GARRITY THOMAS J","owner_url":"/insider/0001275012","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.98,"price_display":"1.98","price_state":"stated","total_value":9900.0,"total_display":"9,900.00","total_whole":"9,900","shares_owned_after":130213.0,"shares_owned_after_display":"130,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-11","filed_date":"2014-08-13","scope":"insider"},{"id":4690288,"accession":"0001181431-13-032085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-032085","line_url":"/filing/0001181431-13-032085#line-1","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001275012","owner_name":"GARRITY THOMAS J","owner_display_name":"GARRITY THOMAS J","owner_url":"/insider/0001275012","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":4.077,"price_display":"4.08","price_state":"stated","total_value":53001.0,"total_display":"53,001.00","total_whole":"53,001","shares_owned_after":125213.0,"shares_owned_after_display":"125,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-31","filed_date":"2013-06-03","scope":"insider"},{"id":3375750,"accession":"0001181431-12-046998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-046998","line_url":"/filing/0001181431-12-046998#line-1","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001275012","owner_name":"GARRITY THOMAS J","owner_display_name":"GARRITY THOMAS J","owner_url":"/insider/0001275012","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31000.0,"shares_display":"31,000","price_per_share":4.0151,"price_display":"4.02","price_state":"stated","total_value":124468.1,"total_display":"124,468.10","total_whole":"124,468","shares_owned_after":110435.0,"shares_owned_after_display":"110,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-20","filed_date":"2012-08-22","scope":"insider"},{"id":9151607,"accession":"0001140361-11-017821","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-11-017821","line_url":"/filing/0001140361-11-017821#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"AIS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001275012","owner_name":"GARRITY THOMAS J","owner_display_name":"GARRITY THOMAS J","owner_url":"/insider/0001275012","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.63,"price_display":"1.63","price_state":"stated","total_value":4890.0,"total_display":"4,890.00","total_whole":"4,890","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-21","filed_date":"2011-03-21","scope":"insider"},{"id":9151606,"accession":"0001140361-11-017821","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-11-017821","line_url":"/filing/0001140361-11-017821#line-1","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"AIS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001275012","owner_name":"GARRITY THOMAS J","owner_display_name":"GARRITY THOMAS J","owner_url":"/insider/0001275012","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":1.5792,"price_display":"1.58","price_state":"stated","total_value":11054.4,"total_display":"11,054.40","total_whole":"11,054","shares_owned_after":47000.0,"shares_owned_after_display":"47,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-18","filed_date":"2011-03-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001016169","name":"ANTARES PHARMA, INC.","url":"/issuer/0001016169","role":"Director","n_filings":12,"first_seen":"2011-03-21","last_seen":"2021-03-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001275012","retrieved_at":"2026-08-23T16:28:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}